1.Dosimetric difference in RapidArc planning for radiotherapy of multiple hepatic malignancy using different photon energy
Guanzhong GONG ; Yong YIN ; Deyin ZHAI ; Tonghai LIU ; Jinlong SONG ; Jie LU ; Jinhu CHEN ; Ruozheng WANG
Journal of International Oncology 2012;39(5):391-395
ObjectiveTo investigate the dosimetric difference in the application of RapidArc using 6 and 15 MV X-rays for radiotherapy of multiple hepatic malignancy.MethodsA total of 12 cases with multiple hepatic tumors ( primary 5 cases and secondary 7 cases) were selected.All patients underwent the three dimensional CT simulation in free breathing.For each patient,RapidArc plans with single or two 358° arcs using 6 or 15 MV X-rays were designed respectively,the prescription dose was 2Gy per fraction × 25 fractions.The dosimetric differences were compared among RapidArc plans.ResultsAll of RapidArc plans could meet the clinicalrequirement.There were no significant differences in the conformity index ( CI ),homogeneity index ( HI),the maximum dose and the minimum dose of PTV among RapidArc plans ( P > 0.05).All the CI could get to 0.91 and HI could get to 0.88.In the RapidArc plans with two 358° arcs,the Vs,V10,V15 of normal liver were higher than with single arc,while V20,V25,V30,V35,V40 were lower than with single arc.There were no significant differences in the different radiation dose of normal liver,stomach,duodenum and spinal cord among different plans ( P >0.05 ).The monitor units of RapidArc plans using 6 MV X-rays increased 12% compared to 15 MV averagely.CondusionThe 6 MV X-ray would be selected chiefly in the radiotherapy of multiple haptic tumor using RapidArc with whole arc(s).
2.Long Noncoding RNA HEIH Promotes Colorectal Cancer Tumorigenesis via Counteracting miR-939-Mediated Transcriptional Repression of Bcl-xL.
Chunhui CUI ; Duanyang ZHAI ; Lianxu CAI ; Qiaobin DUAN ; Lang XIE ; Jinlong YU
Cancer Research and Treatment 2018;50(3):992-1008
PURPOSE: Studies have found that long noncoding RNA HEIH (lncRNA-HEIH) is upregulated and facilitates hepatocellular carcinoma tumor growth. However, its clinical significances, roles, and action mechanism in colorectal cancer (CRC) remains unidentified. MATERIALS AND METHODS: lncRNA-HEIH expression in CRC tissues and cell lines was measured by quantitative real-time polymerase chain reaction. Cell CountingKit-8, ethynyl deoxyuridine incorporation assay, terminal deoxynucleotidyl transferase dUTP nick end labeling staining, and nude mice xenografts assays were performed to investigate the roles of lncRNA-HEIH. RNA pull-down, RNA immunoprecipitation, chromatin immunoprecipitation, and luciferase reporter assays were performed to investigate the action mechanisms of lncRNA-HEIH. RESULTS: In this study, we found that lncRNA-HEIH is significantly increased in CRC tissues and cell lines. lncRNA-HEIH expression is positively associated with tumor size, invasion depth, and poor prognosis of CRC patients. Enhanced expression of lncRNA-HEIH promotes CRC cell proliferation and decreases apoptosis in vitro, and promotes CRC tumor growth in vivo. Whereas knockdown of lncRNA-HEIH inhibits CRC cell proliferation and induces apoptosis in vitro, and suppresses CRC tumor growth in vivo. Mechanistically, lncRNA-HEIH physically binds to miR-939. The interaction between lncRNA-HEIH and miR-939 damages the binding between miR-939 and nuclear factor κB (NF-κB), increases the binding of NF-κB to Bcl-xL promoter, and promotes the transcription and expression of Bcl-xL. Moreover, Bcl-xL expression is positively associatedwith lncRNA-HEIH in CRC tissues. Blocking the interaction between lncRNA-HEIH and miR-939 abolishes the effects of lncRNA-HEIH on CRC tumorigenesis. CONCLUSION: This study demonstrated that lncRNA-HEIH promotes CRC tumorigenesis through counteracting miR-939-mediated transcriptional repression of Bcl-xL, and suggested that lncRNA-HEIH may serve as a prognostic biomarker and therapeutic target for CRC.
Animals
;
Apoptosis
;
Carcinogenesis*
;
Carcinoma, Hepatocellular
;
Cell Line
;
Cell Proliferation
;
Chromatin Immunoprecipitation
;
Colorectal Neoplasms*
;
Deoxyuridine
;
DNA Nucleotidylexotransferase
;
Heterografts
;
Humans
;
Immunoprecipitation
;
In Vitro Techniques
;
Luciferases
;
Mice
;
Mice, Nude
;
Prognosis
;
Real-Time Polymerase Chain Reaction
;
Repression, Psychology*
;
RNA
;
RNA, Long Noncoding*
3.Analysis of the Efficiency and Influencing Factors of Medical Resource Allocation in China
Jinlong ZHAI ; Shuyong FU ; Shiyi CHEN
Herald of Medicine 2024;43(11):1864-1868,后插1
Objective To study the efficiency and influencing factors of medical resource allocation in 30 provinces and cities of China.Methods Evaluating the efficiency of medical resource allocation in three regions in Chinese mainland,including 30 provincial administrative regions from 2009 to 2021 using the three-stage DEA-Tobit model.Results After excluding environmental factors,the mean value of the technical efficiency of medical resource allocation in China showed a slight downward trend.Per capita GDP and population density had a generally positive effect on the adjusted efficiency of medical resource allocation.In the eastern and central regions,the per capita GDP had consistent coefficients of 0.09 for the efficiency of medical resource allocation.Conclusion In regions of China where medical resources are relatively abundant,the allocation efficiency is relatively low,such as in Beijing and Tianjin.Conversely,the allocation efficiency is relatively higher in areas where medical resources are less abundant.
4.The value of hs-CRP and albumin ratio in predicting the prognosis of patients with in-hospital cardiac arrest
Chang LIU ; Jinlong WANG ; Yi ZHONG ; Bei LIU ; Jihui WANG ; Chenglei SU ; Ke CHEN ; Ningjun ZHAO ; Limei ZHAI ; Yigen PENG ; Rong HUA ; Xianliang YAN ; Tie XU
Chinese Journal of Emergency Medicine 2021;30(8):1002-1006
Objective:To investigate the predicting value of high sensitivity C-reactive protein (hs-CRP) and albumin (Alb) ratio on prognosis of patients with in-hospital cardiac arrest (IHCA).Methods:A total of 107 patients with IHCA and spontaneous circulation recovery (ROSC) after cardiopulmonary resuscitation (CPR) in the Affiliated Hospital of Xuzhou Medical University during January 1, 2017 and September 30, 2020 were selected as the subjects and divided into the survival group and death group according to the survival condition on day 14 after IHCA. The correlation between ratio of high sensitivity C-reactive protein/albumin (hs-CRP/Alb) and the prognosis of patients was analyzed.Results:No statistical significant differences were found between the survival and death groups in sex, age, medical history, ECG monitoring, recovery ventilation mode, percentage of first monitoring of heart rate and pre-resuscitation Alb (all P > 0.05). However, there were significant differences in the percentage of non-cardiogenic CA and adrenaline dose > 5 mg, time of CPR, concentrations of blood lactic acid, Alb, hs-CRP, and ratio of hs-CRP/Alb (all P < 0.05). Logistic regression analysis showed that percentage of adrenaline dose > 5 mg, concentration of blood lactic acid, time of CPR, and ratio of hs-CRP/Alb were independent risk factors for predicting death. ROC curve analysis showed that hs-CRP/Alb ratio, and concentration of hs-CRP and Alb had predictive value on the death of patients with IHCA; the areas under the curves of hs-CRP/Alb ratio, hs-CRP and Alb concentration were 0.876, 0.864 and 0.745, respectively. The predictive efficiency of hs-CRP/Alb ratio was better than that of hs-CRP concentration or Alb concentration. Conclusions:hs-CRP/Alb ratio has predictive value for the prognosis of patients with IHCA and the predictive value is superior to that of hs-CRP and Alb concentration.